{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:10:17Z","timestamp":1791828617813,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,27]]},"DOI":"10.7759\/cureus.8860","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T09:30:32Z","timestamp":1593250232000},"source":"Crossref","is-referenced-by-count":29,"title":["Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods"],"prefix":"10.7759","author":[{"given":"Ted George O","family":"Achufusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto A","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divey","family":"Manocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12263-011-0229-7","article-title":"Intestinal microbiota in human health and disease: the impact of probiotics","volume":"6","author":"Gerritsen J","year":"2011","unstructured":"Gerritsen J, Smidt H, Rijkers GT, De vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011, 6:209-240. 10.1007\/s12263-011-0229-7","journal-title":"Genes Nutr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00136","article-title":"Human gut microbiota: repertoire and variations","volume":"2","author":"Lagier JC","year":"2012","unstructured":"Lagier JC, Million M, Hugon P, Armougom F, Raoult D. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol. 2012, 2:136. 10.3389\/fcimb.2012.00136","journal-title":"Front Cell Infect Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus","volume":"112","author":"Rezaie A","year":"2017","unstructured":"Rezaie A, Buresi M, Lembo A, et al.. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus. Am J Gastroenterol. 2017, 112:775-784. 10.1038\/ajg.2017.46","journal-title":"Am J Gastroenterol"},{"key":"ref4","article-title":"Analysis of human microbiome using NGS (Article in Japanese)","volume":"28","author":"Suda W","year":"2018","unstructured":"Suda W, Ogata Y, Nishijima S. Analysis of human microbiome using NGS (Article in Japanese). Clin Calcium. 2018, 28:1274-1281.","journal-title":"Clin Calcium"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12456","article-title":"Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment","volume":"38","author":"Grace E","year":"2013","unstructured":"Grace E, Shaw C, Whelan K, Andreyev HJ. Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther. 2013, 38:674-688. 10.1111\/apt.12456","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12304","article-title":"Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth","volume":"37","author":"Jacobs C","year":"2013","unstructured":"Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SS. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth. Aliment Pharmacol Ther. 2013, 37:1103-1111. 10.1111\/apt.12304","journal-title":"Aliment Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41424-018-0011-x","article-title":"Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)?","volume":"9","author":"Rao SSC","year":"2018","unstructured":"Rao SSC, Tan G, Abdulla H, Yu S, Larion S, Leelasinjaroen P. Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)?. Clin Transl Gastroenterol. 2018, 9:146. 10.1038\/s41424-018-0011-x","journal-title":"Clin Transl Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15133","article-title":"Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease","volume":"49","author":"Shah A","year":"2019","unstructured":"Shah A, Morrison M, Burger D, et al.. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther. 2019, 49:624-635. 10.1111\/apt.15133","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1371-9","article-title":"Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth","volume":"53","author":"Su T","year":"2018","unstructured":"Su T, Lai S, Lee A, He X, Chen S. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. J Gastroenterol. 2018, 53:27-36. 10.1007\/s00535-017-1371-9","journal-title":"J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/971582","article-title":"Duodenal aspirates for small intestine bacterial overgrowth: yield, PPIs, and outcomes after treatment at a tertiary academic medical center","volume":"2015","author":"Franco DL","year":"2015","unstructured":"Franco DL, Disbrow MB, Kahn A, et al.. Duodenal aspirates for small intestine bacterial overgrowth: yield, PPIs, and outcomes after treatment at a tertiary academic medical center. Gastroenterol Res Pract. 2015, 2015:971582. 10.1155\/2015\/971582","journal-title":"Gastroenterol Res Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4726-4","article-title":"A prospective evaluation of ileocecal valve dysfunction and intestinal motility derangements in small intestinal bacterial overgrowth","volume":"62","author":"Chander Roland B","year":"2017","unstructured":"Chander Roland B, Mullin GE, Passi M, Zheng X, Salem A, Yolken R, Pasricha PJ. A prospective evaluation of ileocecal valve dysfunction and intestinal motility derangements in small intestinal bacterial overgrowth. Dig Dis Sci. 2017, 62:3525-3535. 10.1007\/s10620-017-4726-4","journal-title":"Dig Dis Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3166-7","article-title":"Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO)","volume":"59","author":"Roland BC","year":"2014","unstructured":"Roland BC, Ciarleglio MM, Clarke JO, Semler JR, Tomakin E, Mullin GE, Pasricha PJ. Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO). Dig Dis Sci. 2014, 59:1269-1277. 10.1007\/s10620-014-3166-7","journal-title":"Dig Dis Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/151085","article-title":"The gut microbiota and irritable bowel syndrome: friend or foe?","volume":"2012","author":"Ghoshal UC","year":"2012","unstructured":"Ghoshal UC, Shukla R, Ghoshal U, Gwee KA, Ng SC, Quigley EM. The gut microbiota and irritable bowel syndrome: friend or foe?. Int J Inflam. 2012, 2012:151085. 10.1155\/2012\/151085","journal-title":"Int J Inflam"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-007-0060-x","article-title":"Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure","volume":"9","author":"Ziegler TR","year":"2007","unstructured":"Ziegler TR, Cole CR. Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure. Curr Gastroenterol Rep. 2007, 9:463-467. 10.1007\/s11894-007-0060-x","journal-title":"Curr Gastroenterol Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000122","article-title":"Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture","volume":"26","author":"Ghoshal UC","year":"2014","unstructured":"Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur J Gastroenterol Hepatol. 2014, 26:753-760. 10.1097\/MEG.0000000000000122","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3157-8","article-title":"Antibiotic treatment of constipation-predominant irritable bowel syndrome","volume":"59","author":"Pimentel M","year":"2014","unstructured":"Pimentel M, Chang C, Chua KS, Mirocha J, DiBaise J, Rao S, Amichai M. Antibiotic treatment of constipation-predominant irritable bowel syndrome. Dig Dis Sci. 2014, 59:1278-1285. 10.1007\/s10620-014-3157-8","journal-title":"Dig Dis Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03951.x","article-title":"Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference","volume":"29","author":"Gasbarrini A","year":"2009","unstructured":"Gasbarrini A, Corazza GR, Gasbarrini G, et al.. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009, 29:1-49. 10.1111\/j.1365-2036.2009.03951.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1016\/0016-5085(87)90132-6","article-title":"H2 excretion after ingestion of complex carbohydrates","volume":"92","author":"Levitt MD","year":"1987","unstructured":"Levitt MD, Hirsh P, Fetzer CA, Sheahan M, Levine AS. H2 excretion after ingestion of complex carbohydrates. Gastroenterology. 1987, 92:383-389.","journal-title":"Gastroenterology"},{"key":"ref19","article-title":"Small intestinal bacterial overgrowth: a comprehensive review","volume":"3","author":"Dukowicz AC","year":"2007","unstructured":"Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (NY). 2007, 3:112-122.","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223531","article-title":"Small intestinal bacterial overgrowth (SIBO) and vitamin K-responsive coagulopathy: a previously unrecorded association","volume":"2018","author":"Oliveira RB","year":"2018","unstructured":"Oliveira RB, Martinelli ALC, Troncon LEA, Elias J Jr. Small intestinal bacterial overgrowth (SIBO) and vitamin K-responsive coagulopathy: a previously unrecorded association. BMJ Case Rep. 2018, 2018:bcr2017223531. 10.1136\/bcr-2017-223531","journal-title":"BMJ Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2018.04.016","article-title":"Methods for studying gut microbiota: a primer for physicians","volume":"9","author":"Sarangi AN","year":"2019","unstructured":"Sarangi AN, Goel A, Aggarwal R. Methods for studying gut microbiota: a primer for physicians. J Clin Exp Hepatol. 2019, 9:62-73. 10.1016\/j.jceh.2018.04.016","journal-title":"J Clin Exp Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i3.803","article-title":"Application of metagenomics in the human gut microbiome","volume":"21","author":"Wang WL","year":"2015","unstructured":"Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS. Application of metagenomics in the human gut microbiome. World J Gastroenterol. 2015, 21:803-814. 10.3748\/wjg.v21.i3.803","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfu128","article-title":"Combination of metagenomics and culture-based methods to study the interaction between ochratoxin a and gut microbiota","volume":"141","author":"Guo M","year":"2014","unstructured":"Guo M, Huang K, Chen S, et al.. Combination of metagenomics and culture-based methods to study the interaction between ochratoxin a and gut microbiota. Toxicol Sci. 2014, 141:314-323. 10.1093\/toxsci\/kfu128","journal-title":"Toxicol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq345","article-title":"Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system","volume":"65","author":"Maccaferri S","year":"2010","unstructured":"Maccaferri S, Vitali B, Klinder A, et al.. Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother. 2010, 65:2556-2565. 10.1093\/jac\/dkq345","journal-title":"J Antimicrob Chemother"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03259.x","article-title":"High dosage rifaximin for the treatment of small intestinal bacterial overgrowth","volume":"25","author":"Scarpellini E","year":"2007","unstructured":"Scarpellini E, Gabrielli M, Lauritano CE, et al.. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2007, 25:781-786. 10.1111\/j.1365-2036.2007.03259.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta L","year":"2017","unstructured":"Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017, 45:604-616. 10.1111\/apt.13928","journal-title":"Aliment Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12479","article-title":"Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth","volume":"38","author":"Shah SC","year":"2013","unstructured":"Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013, 38:925-934. 10.1111\/apt.12479","journal-title":"Aliment Pharmacol Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmy063","article-title":"Mechanisms of action of probiotics","volume":"10","author":"Plaza-Diaz J","year":"2019","unstructured":"Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr. 2019, 10:S49-66. 10.1093\/advances\/nmy063","journal-title":"Adv Nutr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence","volume":"51","author":"Zhong C","year":"2017","unstructured":"Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence. J Clin Gastroenterol. 2017, 51:300-311. 10.1097\/MCG.0000000000000814","journal-title":"J Clin Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2174\/15748847113089990048","article-title":"Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation","volume":"8","author":"Rosania R","year":"2013","unstructured":"Rosania R, Giorgio F, Principi M, Amoruso A, Monno R, Di Leo A, Ierardi E. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Curr Clin Pharmacol. 2013, 8:169-172. 10.2174\/15748847113089990048","journal-title":"Curr Clin Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41424-018-0030-7","article-title":"Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis","volume":"9","author":"Rao SSC","year":"2018","unstructured":"Rao SSC, Rehman A, Yu S, Andino NM. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clin Transl Gastroenterol. 2018, 9:162. 10.1038\/s41424-018-0030-7","journal-title":"Clin Transl Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7453\/gahmj.2014.019","article-title":"Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth","volume":"3","author":"Chedid V","year":"2014","unstructured":"Chedid V, Dhalla S, Clarke JO, et al.. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014, 3:16-24. 10.7453\/gahmj.2014.019","journal-title":"Glob Adv Health Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/nu4081095","article-title":"Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease","volume":"4","author":"Brown K","year":"2012","unstructured":"Brown K, Decoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012, 4:1095-1119. 10.3390\/nu4081095","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2011.141","article-title":"A vegan or vegetarian diet substantially alters the human colonic faecal microbiota","volume":"66","author":"Zimmer J","year":"2012","unstructured":"Zimmer J, Lange B, Frick JS, et al.. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr. 2012, 66:53-60. 10.1038\/ejcn.2011.141","journal-title":"Eur J Clin Nutr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.24411\/0042-8833-2019-10051","article-title":"Features of nutrition pattern of patients with small intestinal bacterial overgrowth resistant to therapy (Article in Russian)","volume":"88","author":"Pilipenko VI","year":"2019","unstructured":"Pilipenko VI, Isakov VA, Vlasova AV, Naidenova MA. Features of nutrition pattern of patients with small intestinal bacterial overgrowth resistant to therapy (Article in Russian). Vopr Pitan. 2019, 88:31-38. 10.24411\/0042-8833-2019-10051","journal-title":"Vopr Pitan"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1023\/b:ddas.0000011605.43979.e1","article-title":"A 14-day elemental diet is highly effective in normalizing the lactulose breath test","volume":"49","author":"Pimentel M","year":"2004","unstructured":"Pimentel M, Constantino T, Kong Y, Bajwa M, Rezaei A, Park S. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci. 2004, 49:73-77. 10.1023\/b:ddas.0000011605.43979.e1","journal-title":"Dig Dis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/32682-small-intestinal-bacterial-overgrowth-comprehensive-review-of-diagnosis-prevention-and-treatment-methods","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:23:54Z","timestamp":1707488634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/32682-small-intestinal-bacterial-overgrowth-comprehensive-review-of-diagnosis-prevention-and-treatment-methods"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.8860","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,27]]}}}